VAERS Explorer
Back to explore

Report #2880323

Received Jan 1, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
FLU3INFLUENZA (SEASONAL) (FLULAVAL)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (1)

Incorrect route of product administration

Symptom narrative

administered to 17-year-old female using 5/8inch needle in deltoid/ unsure if dose given was intramuscular due to needle size; This non-serious case was reported by a nurse via sales rep and described the occurrence of intramuscular formulation administered by other route in a 17-year-old female patient who received Flu Seasonal TIV Quebec (Flulaval) for prophylaxis. On an unknown date, the patient received Flulaval (unknown deltoid). On an unknown date, an unknown time after receiving Flulaval, the patient experienced intramuscular formulation administered by other route (Verbatim: administered to 17-year-old female using 5/8inch needle in deltoid/ unsure if dose given was intramuscular due to needle size). The outcome of the intramuscular formulation administered by other route was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 30-DEC-2025 The batch number was not provided, and we are unable to contact the reporter.